T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter

Name of the Condition

• Adverse effect of androgens and anabolic congeners, initial encounter

Summary

This condition represents an adverse reaction to androgens or anabolic congeners during an initial encounter. Androgens and anabolic agents are used for therapeutic purposes, such as hormone replacement or anabolic effects, and this code applies when their use results in harmful effects. The "initial encounter" specifies that this is the patient's first presentation for the adverse effect.

Causes

Adverse effects may arise from prescribed or non-prescribed use of androgens or anabolic agents. Causes include allergic reactions, idiosyncratic responses, or dose-related toxicity. The reaction occurs as a direct result of exposure to these substances, even when used within therapeutic guidelines.

Risk Factors

• Therapeutic use of androgens or anabolic agents
• Individual sensitivity to androgenic substances
• Renal or hepatic impairment affecting drug metabolism
• Polypharmacy involving hormonal agents
• Incorrect dosing or administration

Symptoms

Symptoms vary based on the agent and reaction type. Common manifestations include virilization (e.g., hirsutism, voice deepening), hepatotoxicity, electrolyte imbalances, or cardiovascular effects (e.g., hypertension). Other reactions may involve mood changes, skin reactions, or musculoskeletal issues.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and exclusion of other causes. Laboratory tests (e.g., liver function, hormone levels) may support the diagnosis. Documentation must confirm the adverse effect is linked to androgen or anabolic agent use and that this is the initial encounter.

Treatment Options

Treatment focuses on discontinuing the offending agent and managing symptoms. Supportive care (e.g., hydration, electrolyte correction) may be needed. Specific interventions depend on the adverse effect (e.g., antihypertensives for cardiovascular effects). Consultation with specialists (e.g., endocrinology) may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Most cases resolve with agent discontinuation, but some effects (e.g., virilization) may be persistent. Follow-up ensures symptom resolution and monitors for recurrence or complications.

Complications

Complications can include persistent virilization, organ damage (e.g., hepatic or cardiovascular), or delayed recovery. Severe reactions may require prolonged treatment or result in long-term morbidity.

Lifestyle & Prevention

Prevention involves proper medication use, adherence to prescribed dosing, and monitoring for early signs of adverse effects. Patients should report symptoms promptly. Avoid non-prescribed or misuse of androgens/anabolic agents.

When to Seek Professional Help

Seek care if symptoms worsen, new symptoms develop, or if there is uncertainty about the cause. Immediate attention is needed for severe reactions (e.g., chest pain, jaundice, or significant electrolyte imbalances).

Tips for Medical Coders

Use this code for the initial encounter of an adverse effect from androgens or anabolic congeners. Document the substance involved, the nature of the adverse effect, and confirm this is the first presentation. Ensure the encounter is not for poisoning, underdosing, or subsequent care of the adverse effect.